{"id":76515,"date":"2025-12-31T16:38:14","date_gmt":"2025-12-31T07:38:14","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/tnf-inhibitors-market-mordor\/"},"modified":"2026-10-02T18:37:47","modified_gmt":"2026-10-02T09:37:47","slug":"tnf-inhibitors-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/tnf-inhibitors-market-mordor\/","title":{"rendered":"\u816b\u760d\u58ca\u6b7b\u56e0\u5b50\u963b\u5bb3\u5264\u5e02\u5834\u306e\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/tnf-inhibitors-market_1662372312719_Logo-TNF_inhibitors.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/tnf-inhibitors-market-size-image-1735458956875.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u4e16\u754c\u7684\u306a\u6709\u75c5\u7387\u306e\u5897\u52a0\u3068\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u7c73\u56fdFDA\u306b\u3088\u308b\u533b\u85ac\u54c1\u627f\u8a8d\u8fc5\u901f\u5316\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u3092\u4f34\u3046\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u306e\u65b0\u88fd\u54c1\u767a\u58f2<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u5236\u7d04<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u5fc3\u4e0d\u5168\u3001\u809d\u969c\u5bb3\u3001\u795e\u7d4c\u75be\u60a3\u3001\u4e7e\u766c\u3001\u304a\u3088\u3073\u591a\u304f\u306e\u30bf\u30a4\u30d7\u306e\u30a2\u30ec\u30eb\u30ae\u30fc\u53cd\u5fdc\u306a\u3069\u306e\u5408\u4f75\u75c7\u306e\u9ad8\u3044\u30ea\u30b9\u30af<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u958b\u767a\u6bb5\u968e\u3067\u306e\u9ad8\u3044\u8ab2\u984c\u3068\u9ad8\u4fa1\u306a\u7279\u8a31\u53d6\u5f97\u6e08\u307f\u30d0\u30a4\u30aa\u533b\u85ac\u54c1<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 (\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 &#8211; USD\u767e\u4e07)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u85ac\u5264\u30af\u30e9\u30b9\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u30a2\u30c0\u30ea\u30e0\u30de\u30d6<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u30ea\u30c4\u30ad\u30b7\u30de\u30d6<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u9069\u5fdc\u75c7\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u30af\u30ed\u30fc\u30f3\u75c5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u4e7e\u766c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.4 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u75c5\u9662\u85ac\u5c40<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u5c02\u9580\u85ac\u5c40<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u4e89\u74b0\u5883<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u6982\u8981<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 UCB Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 Pfizer Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 Amgen Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 AbbVie Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 Johnson &amp; Johnson<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 F. Hoffmann-La Roche AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 Boehringer Ingelheim Pharmaceuticals<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 Novartis International AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 Merck kGaA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 Lupin<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.11 Sanofi<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.12 Bristol-Myers Squibb Company<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.13 Cadila Healthcare Ltd<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\u5229\u7528\u53ef\u80fd\u6027\u306b\u3088\u308b<\/div>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306b\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u307e\u3059\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u300c\u816b\u760d\u58ca\u6b7b\u56e0\u5b50\u963b\u5bb3\u5264\u5e02\u5834\uff1a\u6210\u9577\u30c8\u30ec\u30f3\u30c9\u3068\u4e88\u6e2c\uff082025\u5e74\uff5e2030\u5e74\uff09\u300d\u306b\u95a2\u3059\u308b\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e02\u5834\u304c2025\u5e74\u306b410.9\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u306b\u306f490.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u4e2d\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff093.59%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306f\u3001\u85ac\u5264\u30af\u30e9\u30b9\u5225\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u3001\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u3001\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3001\u305d\u306e\u4ed6\uff09\u3001\u9069\u5fdc\u75c7\u5225\uff08\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3001\u30af\u30ed\u30fc\u30f3\u75c5\u3001\u4e7e\u766c\u3001\u305d\u306e\u4ed6\uff09\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff08\u75c5\u9662\u85ac\u5c40\u3001\u5c02\u9580\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u5225\uff08\u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\uff09\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306f\u3001\u4e16\u754c\u7684\u306a\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u6df7\u4e71\u306b\u3088\u308a\u3001\u5e02\u5834\u306e\u6210\u9577\u306b\u524d\u4f8b\u306e\u306a\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3057\u305f\u3002\u3057\u304b\u3057\u3001TNF\u963b\u5bb3\u5264\u306fCOVID-19\u306e\u6cbb\u7642\u306b\u5e83\u304f\u5fdc\u7528\u3055\u308c\u3001\u9700\u8981\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3057\u305f\u3002\u4f8b\u3048\u3070\u30012021\u5e7410\u6708\u306bJournal of American Medical Association\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u3067\u306f\u3001\u514d\u75ab\u4ecb\u5728\u6027\u708e\u75c7\u6027\u75be\u60a3\u3092\u6301\u3064\u500b\u4eba\u306b\u304a\u3044\u3066\u3001TNF\u963b\u5bb3\u5264\u5358\u5264\u7642\u6cd5\u304c\u4ed6\u306e\u4e00\u822c\u7684\u306b\u51e6\u65b9\u3055\u308c\u308b\u514d\u75ab\u8abf\u7bc0\u6cbb\u7642\u30ec\u30b8\u30e1\u30f3\u3068\u6bd4\u8f03\u3057\u3066\u3001COVID-19\u306e\u6709\u5bb3\u306a\u8ee2\u5e30\u306e\u30ea\u30b9\u30af\u4f4e\u4e0b\u3068\u95a2\u9023\u3057\u3066\u3044\u308b\u3068\u7d50\u8ad6\u4ed8\u3051\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306b\u3001COVID-19\u60a3\u8005\u306b\u304a\u3051\u308bTNF\u5358\u5264\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3092\u793a\u3059\u7814\u7a76\u306f\u3001\u5e02\u5834\u306e\u6210\u9577\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u3001SARS-CoV-2\u30a6\u30a4\u30eb\u30b9\u306e\u69d8\u3005\u306a\u5909\u7570\u682a\u306e\u51fa\u73fe\u3084\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u6cbb\u7642\u3078\u306e\u95a2\u5fc3\u306e\u9ad8\u307e\u308a\u306b\u3088\u308a\u3001\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u5f8c\u306eTNF\u963b\u5bb3\u5264\u306e\u9700\u8981\u306f\u5f15\u304d\u7d9a\u304d\u5805\u8abf\u3067\u3042\u308b\u3068\u4e88\u60f3\u3055\u308c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u306b\u8ca2\u732e\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6210\u9577\u306e\u4e3b\u306a\u8981\u56e0\u306f\u3001\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\uff08RA\uff09\u3001\u708e\u75c7\u6027\u8178\u75be\u60a3\u3001\u4e7e\u766c\u3001\u30af\u30ed\u30fc\u30f3\u75c5\u306a\u3069\u306e\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u4e16\u754c\u7684\u306a\u6709\u75c5\u7387\u306e\u5897\u52a0\u3068\u3001\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3067\u3059\u3002\u4f8b\u3048\u3070\u3001\u56fd\u969b\u6d88\u5316\u5668\u75be\u60a3\u8ca1\u56e3\uff08IFFGD\uff09\u304c2021\u5e74\u306b\u767a\u8868\u3057\u305f\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u4e16\u754c\u4eba\u53e3\u306e\u7d0410\uff5e15%\u304c\u904e\u654f\u6027\u8178\u75c7\u5019\u7fa4\u306b\u7f79\u60a3\u3057\u3066\u304a\u308a\u3001\u7c73\u56fd\u3067\u306f\u7d042,500\u4e07\uff5e4,500\u4e07\u4eba\u304c\u3053\u306e\u75be\u60a3\u306b\u82e6\u3057\u3093\u3067\u3044\u307e\u3059\u3002\u307e\u305f\u3001CDC\u304c2021\u5e744\u6708\u306e\u4e16\u754cIBD\u30c7\u30fc\u306b\u767a\u8868\u3057\u305f\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u4e16\u754c\u4e2d\u3067\u5e74\u9593\u7d04700\u4e07\u4eba\u304cIBD\u306b\u7f79\u60a3\u3057\u3066\u304a\u308a\u3001\u904e\u53bb20\u5e74\u9593\u3067\u75be\u60a3\u306e\u6709\u75c5\u7387\u304c\u8457\u3057\u304f\u5897\u52a0\u3057\u3066\u3044\u308b\u3068\u8ff0\u3079\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u69d8\u3005\u306a\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u767a\u751f\u7387\u306e\u5897\u52a0\u306f\u3001TNF\u963b\u5bb3\u5264\u306e\u3088\u3046\u306a\u52b9\u679c\u7684\u306a\u6cbb\u7642\u6cd5\u3084\u6cbb\u7642\u85ac\u306e\u9700\u8981\u3092\u4fc3\u9032\u3057\u3001\u5e02\u5834\u306e\u6210\u9577\u306b\u8ca2\u732e\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u3055\u3089\u306b\u3001\u5b89\u5168\u3067\u52b9\u679c\u7684\u306a\u6cbb\u7642\u85ac\u3092\u63d0\u4f9b\u3059\u308b\u305f\u3081\u306e\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u88fd\u54c1\u627f\u8a8d\u3082\u5e02\u5834\u306e\u6210\u9577\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e7412\u6708\u306b\u306f\u3001Coherus BioSciences, Inc.\u304c\u3001\u30d2\u30e5\u30df\u30e9\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\uff09\u306e\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u88fd\u54c1\u3067\u3042\u308bYUSIMRY\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6-aqvh\u3001\u65e7CHS-1420\uff09\u306b\u3064\u3044\u3066\u3001\u7c73\u56fdFDA\u306e\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002YUSIMRY\u306f\u3001\u5c0b\u5e38\u6027\u4e7e\u766c\u3001\u4e7e\u766c\u6027\u95a2\u7bc0\u708e\u3001\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3001\u82e5\u5e74\u6027\u7279\u767a\u6027\u95a2\u7bc0\u708e\u3001\u5f37\u76f4\u6027\u810a\u690e\u708e\u3001\u30af\u30ed\u30fc\u30f3\u75c5\u3001\u6f70\u760d\u6027\u5927\u8178\u708e\u306b\u9069\u5fdc\u3055\u308c\u307e\u3059\u3002<br \/>\n\u3057\u304b\u3057\u306a\u304c\u3089\u3001\u5408\u4f75\u75c7\u306e\u30ea\u30b9\u30af\u304c\u9ad8\u3044\u3053\u3068\u3001\u958b\u767a\u6bb5\u968e\u3067\u306e\u8ab2\u984c\u3001\u304a\u3088\u3073\u9ad8\u4fa1\u306a\u7279\u8a31\u53d6\u5f97\u6e08\u307f\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u304c\u5e02\u5834\u306e\u6210\u9577\u3092\u59a8\u3052\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u30bb\u30b0\u30e1\u30f3\u30c8\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5927\u304d\u306a\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\uff08RA\uff09\u306f\u3001\u81ea\u8eab\u306e\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u304c\u4f53\u306e\u5065\u5eb7\u306a\u7d44\u7e54\u3092\u653b\u6483\u3059\u308b\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u3067\u3059\u3002\u751f\u7269\u5b66\u7684\u88fd\u5264\u306f\u3001\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u306e\u53cd\u5fdc\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u308b\u708e\u75c7\u306e\u539f\u56e0\u3068\u306a\u308b\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u3068\u547c\u3070\u308c\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3059\u308b\u3053\u3068\u3067\u4f5c\u7528\u3057\u307e\u3059\u3002\u300c\u6297TNF\u300d\u85ac\u306e\u5834\u5408\u3001\u6a19\u7684\u3068\u306a\u308b\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u306f\u300cTNF\uff08\u816b\u760d\u58ca\u6b7b\u56e0\u5b50\u30a2\u30eb\u30d5\u30a1\uff09\u300d\u3068\u3057\u3066\u77e5\u3089\u308c\u3066\u3044\u307e\u3059\u3002RA\u75be\u60a3\u306e\u8ca0\u62c5\u306e\u5897\u52a0\u3001\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u85ac\u5264\u306e\u627f\u8a8d\u3001\u304a\u3088\u3073\u5e02\u5834\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u3088\u308b\u88fd\u54c1\u306e\u767a\u58f2\u3068\u3044\u3063\u305f\u8981\u56e0\u304c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002Global RA Network\u306e2021\u5e74\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u30012021\u5e74\u306b\u306f\u4e16\u754c\u4e2d\u30673\u51045,000\u4e07\u4eba\u4ee5\u4e0a\u304c\u95a2\u7bc0\u708e\u3068\u5171\u306b\u751f\u6d3b\u3057\u3066\u304a\u308a\u3001\u4e16\u754c\u7684\u306a\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u306a\u3069\u69d8\u3005\u306a\u8981\u56e0\u306b\u3088\u308a\u3001\u305d\u306e\u8ca0\u62c5\u306f\u5897\u52a0\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u9ad8\u3044\u6709\u75c5\u7387\u3082\u3001\u8abf\u67fb\u5bfe\u8c61\u5e02\u5834\u306e\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n\u3055\u3089\u306b\u3001\u5730\u57df\u306e\u7570\u306a\u308b\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u85ac\u5264\u306e\u627f\u8a8d\u3084\u88fd\u54c1\u306e\u767a\u58f2\u304c\u3001\u8abf\u67fb\u5bfe\u8c61\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e743\u6708\u306b\u306f\u3001Samsung Bioepis\u304cMerck &#038; Co.\u3068\u306e\u63d0\u643a\u306b\u3088\u308a\u3001\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u3067\u3042\u308bHadlima\u3092\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3067\u767a\u58f2\u3057\u307e\u3057\u305f\u3002Hadlima\u306f\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3067\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u304a\u3088\u3073\u305d\u306e\u4ed6\u306e\u9069\u5fdc\u75c7\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u306e\u305f\u3081\u306e\u6297TNF\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u306e\u767a\u58f2\u306f\u3001\u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5317\u7c73\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u3001\u5e02\u5834\u3067\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u5317\u7c73\u306f\u3001\u4e88\u6e2c\u671f\u9593\u3092\u901a\u3058\u3066TNF\u963b\u5bb3\u5264\u5e02\u5834\u5168\u4f53\u3067\u4e3b\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3053\u306e\u512a\u4f4d\u6027\u306f\u3001\u78ba\u7acb\u3055\u308c\u305f\u76f4\u63a5\u511f\u9084\u653f\u7b56\u3084\u3001\u3053\u306e\u5730\u57df\u306b\u304a\u3051\u308b\u9ad8\u5ea6\u306a\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u306e\u5229\u7528\u53ef\u80fd\u6027\u306a\u3069\u3001\u3044\u304f\u3064\u304b\u306e\u8981\u56e0\u306b\u3088\u308b\u3082\u306e\u3067\u3059\u3002<br \/>\n\u4e16\u754c\u5404\u56fd\u306b\u304a\u3051\u308b\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u8ca0\u62c5\u306e\u5897\u52a0\u3082\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012022\u5e74\u306e\u30af\u30ed\u30fc\u30f3\u75c5\u30fb\u5927\u8178\u708e\u8ca1\u56e3\u306e\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u30af\u30ed\u30fc\u30f3\u75c5\u3068\u6f70\u760d\u6027\u5927\u8178\u708e\u304c160\u4e07\u4eba\u306e\u30a2\u30e1\u30ea\u30ab\u4eba\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u304a\u308a\u3001\u305d\u306e\u307b\u3068\u3093\u3069\u304c35\u6b73\u672a\u6e80\u3067\u3042\u308b\u3068\u8ff0\u3079\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u540c\u69d8\u306b\u3001\u30ab\u30ca\u30c0\u653f\u5e9c\u7d71\u8a08\u5c40\u304c2022\u5e748\u6708\u306b\u767a\u8868\u3057\u305f\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u30012021\u5e74\u306e\u30ab\u30ca\u30c0\u306b\u304a\u3051\u308b\u95a2\u7bc0\u708e\u60a3\u8005\u6570\u306f6,087,600\u4eba\u3067\u3057\u305f\u3002\u5317\u7c73\u8af8\u56fd\u306b\u304a\u3051\u308b\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u9ad8\u3044\u6709\u75c5\u7387\u306f\u3001\u52b9\u679c\u7684\u306a\u6cbb\u7642\u85ac\u306e\u9700\u8981\u3092\u4fc3\u9032\u3057\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u307e\u305f\u3001\u5317\u7c73\u306e\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u88fd\u54c1\u627f\u8a8d\u624b\u7d9a\u304d\u306e\u52a0\u901f\u3082\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u63a8\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012022\u5e742\u6708\u306b\u306f\u3001Pfizer Inc.\u304c\u3001ABRILADA\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6-AFB\uff09\u3092\u30d2\u30e5\u30df\u30e9\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\uff09\u306e\u4e92\u63db\u6027\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u3068\u3057\u3066\u3001\u751f\u7269\u5b66\u7684\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u306e\u4e8b\u524d\u627f\u8a8d\u88dc\u8db3\uff08PAS\uff09\u306e\u5be9\u67fb\u3092\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002<br \/>\n\u3057\u305f\u304c\u3063\u3066\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0\u3001\u4e3b\u8981\u306a\u5e02\u5834\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u5b58\u5728\u3001\u983b\u7e41\u306a\u88fd\u54c1\u767a\u58f2\u306a\u3069\u306e\u4e0a\u8a18\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u5317\u7c73\u5730\u57df\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6709\u5229\u306a\u6210\u9577\u3092\u793a\u3059\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<br \/>\nTNF\u963b\u5bb3\u5264\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u7af6\u4e89\u304c\u3042\u308a\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u3067\u69cb\u6210\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u30b7\u30a7\u30a2\u306e\u89b3\u70b9\u304b\u3089\u306f\u3001\u5c11\u6570\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u304c\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u90e8\u306e\u8457\u540d\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306f\u3001\u4e16\u754c\u4e2d\u3067\u5e02\u5834\u3067\u306e\u5730\u4f4d\u3092\u56fa\u3081\u308b\u305f\u3081\u306b\u4ed6\u306e\u4f01\u696d\u3092\u8cb7\u53ce\u3057\u3066\u304a\u308a\u3001\u307e\u305f\u65b0\u3057\u3044\u88fd\u54c1\u3092\u767a\u58f2\u3057\u3066\u3044\u307e\u3059\u3002\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u308b\u4f01\u696d\u306b\u306f\u3001Abbvie Inc\u3001Pfizer Inc\u3001Johnson &#038; Johnson\u3001Amgen Inc\u3001UCB Inc\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<br \/>\n*   2022\u5e747\u6708\uff1aSandoz\u306f\u3001\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fcHyrimoz\uff08\u30a2\u30c0\u30ea\u30e0\u30de\u30d6-adaz\uff09\u306e\u9ad8\u6fc3\u5ea6\u88fd\u5264\uff08100 mg\/mL\uff09\uff08HCF\uff09\u306b\u95a2\u3059\u308b\u88dc\u8db3\u751f\u7269\u5b66\u7684\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08sBLA\uff09\u306e\u5be9\u67fb\u3092\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002<br \/>\n*   2022\u5e742\u6708\uff1aMyMD Pharmaceuticals Inc.\u306f\u3001MYMD-1\u304c\u5065\u5eb7\u306a\u30d2\u30c8\u88ab\u9a13\u8005\u306e\u8840\u6db2\u4e2d\u306e\u816b\u760d\u58ca\u6b7b\u56e0\u5b50\u30a2\u30eb\u30d5\u30a1\uff08TNF-\u03b1\uff09\uff08\u8001\u5316\u306e\u6839\u672c\u539f\u56e0\u3068\u306a\u308b\u5206\u5b50\uff09\u3092\u6e1b\u5c11\u3055\u305b\u308b\u3053\u3068\u3092\u793a\u3059\u7b2c1\u76f8\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u6cbb\u7642\u306b\u7528\u3044\u3089\u308c\u308bTNF\u963b\u5bb3\u5264\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002TNF-\u03b1\u306f\u5168\u8eab\u6027\u708e\u75c7\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3059\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u30ab\u30b9\u30b1\u30fc\u30c9\u306e\u6700\u521d\u306e\u8981\u7d20\u3067\u3042\u308a\u3001\u69d8\u3005\u306a\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u539f\u56e0\u3068\u3057\u3066\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002TNF\u963b\u5bb3\u5264\u306f\u3001\u3053\u308c\u3089\u306e\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u308b\u640d\u50b7\u3092\u56de\u5fa9\u3055\u305b\u308b\u85ac\u5264\u3067\u3059\u3002<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u306f\u30012024\u5e74\u306b396.1\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012025\u5e74\u306b\u306f410.9\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u30012025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff093.59%\u3067\u6210\u9577\u3057\u30012030\u5e74\u306b\u306f490.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u4e16\u754c\u7684\u306a\u6709\u75c5\u7387\u306e\u5897\u52a0\u3068\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08USFDA\uff09\u306b\u3088\u308b\u8fc5\u901f\u306a\u533b\u85ac\u54c1\u627f\u8a8d\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306b\u4f34\u3046\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u306e\u65b0\u88fd\u54c1\u767a\u58f2\u3082\u3001\u5e02\u5834\u62e1\u5927\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u963b\u5bb3\u3059\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u5fc3\u4e0d\u5168\u3001\u809d\u969c\u5bb3\u3001\u795e\u7d4c\u75be\u60a3\u3001\u4e7e\u766c\u3001\u591a\u304f\u306e\u30a2\u30ec\u30eb\u30ae\u30fc\u53cd\u5fdc\u3068\u3044\u3063\u305f\u5408\u4f75\u75c7\u306e\u9ad8\u3044\u30ea\u30b9\u30af\u3084\u3001\u958b\u767a\u6bb5\u968e\u306b\u304a\u3051\u308b\u9ad8\u3044\u8ab2\u984c\u3001\u305d\u3057\u3066\u9ad8\u4fa1\u306a\u7279\u8a31\u53d6\u5f97\u6e08\u307f\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u672c\u5e02\u5834\u306f\u3001\u85ac\u5264\u30af\u30e9\u30b9\u3001\u9069\u5fdc\u75c7\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u3001\u304a\u3088\u3073\u5730\u57df\u306b\u57fa\u3065\u3044\u3066\u8a73\u7d30\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u85ac\u5264\u30af\u30e9\u30b9\u5225\u3067\u306f\u3001\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u3001\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u3001\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3001\u305d\u306e\u4ed6\u306b\u5206\u985e\u3055\u308c\u307e\u3059\u3002<br \/>\n\u9069\u5fdc\u75c7\u5225\u3067\u306f\u3001\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3001\u30af\u30ed\u30fc\u30f3\u75c5\u3001\u4e7e\u766c\u3001\u305d\u306e\u4ed6\u304c\u542b\u307e\u308c\u307e\u3059\u3002<br \/>\n\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u3067\u306f\u3001\u75c5\u9662\u85ac\u5c40\u3001\u5c02\u9580\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u304c\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\u306b\u5206\u3051\u3089\u308c\u3001\u305d\u308c\u305e\u308c\u4e3b\u8981\u56fd\uff08\u4f8b\uff1a\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\u3001\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u3001\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u306a\u3069\uff09\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u30022025\u5e74\u306b\u306f\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3044\u3066\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\uff08\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u88fd\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\uff09\u3092\u901a\u3058\u3066\u3001\u5e02\u5834\u306e\u7af6\u4e89\u74b0\u5883\u3082\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u7af6\u5408\u4f01\u696d\u3068\u3057\u3066\u306f\u3001UCB Inc\u3001Pfizer Inc\u3001Amgen Inc\u3001AbbVie Inc\u3001Johnson &#038; Johnson\u3001F. Hoffmann-La Roche AG\u3001Boehringer Ingelheim Pharmaceuticals\u3001Novartis International AG\u3001Merck kGaA\u3001Lupin\u3001Sanofi\u3001Bristol-Myers Squibb Company\u3001Cadila Healthcare Ltd\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u306f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u3068\u3057\u3066\u6d3b\u52d5\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3057\u3066\u304a\u308a\u3001\u5e02\u5834\u53c2\u52a0\u8005\u306b\u3068\u3063\u3066\u8cb4\u91cd\u306a\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76515"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=76515"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76515\/revisions"}],"predecessor-version":[{"id":76518,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76515\/revisions\/76518"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=76515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=76515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=76515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}